PeerScope B System™ Clinical Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01483040|
Recruitment Status : Completed
First Posted : December 1, 2011
Last Update Posted : November 8, 2012
The PeerScope B System™ by PeerMedical Ltd. is intended to provide visualization (via a video monitor) and therapeutic access to the lower intestinal tract. The lower intestinal tract includes, but is not restricted to the organs, tissues and subsystems: large bowel and cecum. The device is introduced rectally, as with any standard colonoscope when indications consistent with the need for the procedure are observed in the adult patient population.
The purpose of this prospective clinical study is to establish the usability of the PeerScope B System™ when used during standard colonoscopy procedure.
The study population is comprised of patients indicated for colonoscopy.
The primary endpoint is reaching the cecum of the colon with PeerScope B System™.Secondary endpoints:
- The first secondary endpoint is the incidence of complications using the PeerMedical colonoscope.
- The second secondary endpoint is successful therapeutic interventions as biopsies, polypectomies, APC etc.
- The third secondary endpoint is the procedure time.
- The fourth secondary endpoint is the subjective evaluation of the additional view angle by the physician.
- The fifth secondary endpoint is patient satisfactory.
|Condition or disease||Intervention/treatment||Phase|
|Colon Cancer Colon Diseases Colon Polyps Colon Adenomas||Device: colonoscopy system (PeerScope B System™)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||a Prospective Clinical Study to Establish the Usability of the PeerScope B System™ When Used During Standard Colonoscopy Procedure|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||November 2011|
|Actual Study Completion Date :||November 2011|
- Device: colonoscopy system (PeerScope B System™)
Cancer of the colon and rectum is second only to lung cancer as the leading cause of cancer-related deaths in the United States.Each year, about 1.23 million new cases of bowel cancer are diagnosed worldwide, 333,000 in Europe alone. Colorectal cancer almost always starts in a benign growth called a polyp. Polyps originate in the inner lining of the colon, where they may be visible in a screening test known as colonoscopy. Recent research has shown that appropriate screening and treatment can alleviate much of the suffering associated with colorectal cancer and reduce the number of deaths caused by this malignancy
- The primary endpoint is reaching the cecum of the colon with PeerScope B S [ Time Frame: 6 month ]a full colonoscopy procedure is characterized by reaching an anatomical mark (cecum)at the end of the insertion phase and then the physician start the withdrawal screening phase
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01483040
|Elisha Medical Center|
|Principal Investigator:||Ian Gralnek, Prof.||Ministry of Health, Israel|